Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coli
Open Access
- 1 October 1984
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 26 (4) , 498-500
- https://doi.org/10.1128/aac.26.4.498
Abstract
Niridazole (Ambilhar) and three other newly synthesized nitrothiazole derivatives were highly active against 19 microaerophilic campylobacters (minimum concentration required to inhibit 50% of strains [MIC50], 0.0075 to 0.015 mg/liter). There were, however, considerable differences in the susceptibility among strains tested, and one nitrothiazole derivative was rather inactive (MIC50, 2 mg/liter). Nitroimidazole derivatives, such as metronidazole and tinidazole, were less active (MIC50, 2 and 4 mg/liter, respectively). The nitrofuran derivatives, such as nitrofurazone and nitrofurantoin, were also less active (MIC50, 1 mg/liter). Niridazole and another potent nitrothiazole derivative killed the campylobacters rapidly at low concentrations. In contrast, much higher concentrations of metronidazole were required to achieve bactericidal values.This publication has 9 references indexed in Scilit:
- Antibacterial effects of niridazole: Its effect on microaerophilic campylobacterInfection, 1984
- In vitro susceptibilities of 40 Campylobacter fetus subsp. jejuni strains to niridazole and metronidazoleAntimicrobial Agents and Chemotherapy, 1984
- Antibakterielle wirkung von niridazol II. Wirkung auf aerobe und anaerobe bakterienZentralblatt für Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale. A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie, 1982
- Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteriaAntimicrobial Agents and Chemotherapy, 1982
- Improved media for growth and aerotolerance of Campylobacter fetusJournal of Clinical Microbiology, 1978
- Campylobacter enteritis: a "new" disease.BMJ, 1977
- Trial of ambilhar, a nitrothiazole derivative, in S. mansoni infections in Tanzania.BMJ, 1966